bw 501c has been researched along with xylamidine in 2 studies
| Studies (bw 501c) | Trials (bw 501c) | Recent Studies (post-2010) (bw 501c) | Studies (xylamidine) | Trials (xylamidine) | Recent Studies (post-2010) (xylamidine) |
|---|---|---|---|---|---|
| 17 | 0 | 0 | 29 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cohen, ML; Fuller, RW; Kurz, KD; Mason, NR | 1 |
| Trist, DG; Weatherall, M | 1 |
2 other study(ies) available for bw 501c and xylamidine
| Article | Year |
|---|---|
Antagonism of a peripheral vascular but not an apparently central serotonergic response by xylamidine and BW 501C67.
Topics: Amidines; Animals; Blood Pressure; Cerebral Cortex; Corticosterone; Decerebrate State; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Quipazine; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Serotonin; Serotonin Antagonists | 1986 |
Inhibition of human lymphocyte transformation by two aryloxyalkylamidines.
Topics: Amidines; Chromium Radioisotopes; DNA; Humans; In Vitro Techniques; Lymphocyte Activation; Mitosis; Phytohemagglutinins; Potassium; Thymidine; Time Factors | 1982 |